Robotic Surgeons (Global Market)

Consumables for robotic surgeons

2023: Global Market for Robotic Surgeons Consumables Reaches $4.87 Billion

At the end of 2023, the global market for consumables for robotic surgery reached $4.87 billion. In the future, its steady growth is expected against the background of the development of relevant medical technologies. This is stated in the study of ResearchAndMarkets.com, the results of which were published on May 23, 2024.

Analysts note that the dynamic expansion of the industry in question is driven by ongoing technological advances in virtual reality, augmented reality and surgical systems. Even more growth is driven by significant investments by major healthcare players in research and development related to the digitalization of operating rooms.

𝓲

Фото: Unsplash

The introduction of specialized consumables for robotic surgery into the healthcare sector has led to transformational changes, yielding numerous benefits. Among them are called increased surgical accuracy and an expanding range of procedures that can be carried out with greater accuracy and effectiveness. For patients, this means improved surgical outcomes as well as the minimally invasive nature of many surgical interventions. This promotes faster recovery from the procedure and shorter hospital stays. In addition, the adoption of robotic systems increases the overall performance and efficiency of operating rooms, which allows more patients to be served.

The ResearchAndMarkets.com study says that during 2023-2033, the CAGR (compound percentage CAGR) in the global market for consumables for robotic surgeons will be 12.34%. Thus, it is expected that by the end of this period, costs will reach approximately $15.61 billion.^[1]

Surgical Navigation Systems

2017: Sales of $673.1 million - Coherent Market Insights.

In 2017, the global market for surgical navigation systems amounted to $673.1 million, according to the analytical company Coherent Market Insights. According to experts, the costs of medical institutions for such equipment will grow by 6.9% per year in the period from 2018 to 2026.

The researchers associate the main drivers of growth in sales of surgical navigation systems with the countries of the Asia-Pacific region, Latin America, the Middle East and Africa - these markets are poorly developed, but are financially attractive for manufacturers.

The market for surgical navigation systems for 2017 was estimated at $673 million

The surgical navigation control system is an intraoperative visualization facility allowing to receive real-time information on anatomical features of the patient, location of instruments, state of pathology during planning and during operation.

Coherent Market Insights divides navigation systems for surgeons into the following categories, depending on the application:

• neurosurgical; 
• orthopedic;
• cardiac;
• otolaryngological.

The most popular category is neuronavigation due to the growing number of neurological disorders and brain tumors.

Modern neurosurgical navigation systems allow the surgeon to navigate the complex anatomy of the neurosurgical wound during the operation and perform surgical manipulations with minimal trauma to the surrounding tissues.

In terms of technology, surgical navigation systems are divided into:

• optical;
• electromagnetic;
• hybrid.

Optical solutions are most common due to their advantages over electromagnetic systems, such as the lack of electromagnetic exposure. At the same time, the hybrid equipment segment will grow rapidly by combining the capabilities of optical and electromagnetic systems.^[2]

The following companies are called the leaders of the global market for surgical navigation by analysts:

• Medtronic;
• Stryker Corporation;
• Brainlab;
• B. Braun;
• Scopis;
• Fiagon;
• Zimmer Biomet Holdings;
• Amplitude Surgical;
• Siemens Healthcare.

Robots surgeons

2023: Global robot surgeons' sales rise to $3.25 billion

In 2023, the global market for robotic surgical systems reached $3.25 billion. For comparison, in 2022, costs were estimated at $2.8 billion. Thus, growth was recorded at about 15%. In the future, the industry will show steady positive dynamics, as stated in the Market Research Future review, published in mid-July 2024.

One of the key factors in the growth of analysts is the increasing need for minimally invasive procedures. In such operations, robotic installations allow surgeons to maximize efficiency and accuracy while reducing the risk of complications after treatment. In addition, compared to traditional open surgery, robots provide a faster recovery period, less likelihood of blood loss and infection. The number of postoperative scars is reduced. Plus, surgeons get the opportunity to operate on hard-to-reach areas of the body. Robotic systems are widely used in gynecology and urology, especially in surgeries such as hysterectomy and prostatectomy.

Another market driver is technological progress. The latest advances in robotics, artificial intelligence and machine learning are leading to more functional and accurate robotic surgical complexes. Such installations allow complex operations with a high chance of success. The use of robotic equipment expands the possibilities in the field of telemedicine and remote surgery. Medics can provide treatment at a distance, providing access to specialized care in rural or underserved regions.

Robotic surgeries are cost-effective for healthcare systems because they provide cost-cutting over time thanks to less long hospital stays, fewer complications and faster rehabilitation. Moreover, savings can be achieved even despite high initial capital expenditures. On the other hand, it is the significant cost of the equipment that hinders the wider adoption of robotic surgical platforms.

Key players in the industry include Stryker Corporation, Titan Medical, Intuitive Surgical, Transenterix, Medtronic, Zimmer Biomet Holdings, Smith & Nephew, Globus Medical, Siemens AG (Siemens Healthineers) and Johnson & Johnson. The North American region is the largest market for robotic surgical complexes: in 2022, it accounted for about $1.3 billion in costs, or more than 46% of the total industry. Growth here is supported by the rapid development of technology, increased investment in research and development, and an expansion of the field of application. Europe is in second place in terms of the cost of robotic surgeons, and the Asia-Pacific region closes the top three with the highest growth rate.

The robotic surgical systems market segmentation by surgery type includes gynaecological surgery, urological surgery, neurosurgery, orthopaedic surgery, general surgery, etc. Orthopaedic surgery provided the most revenue in 2023.

According to Market Research Future analysts, the global market for robotic surgeons will demonstrate a CAGR (CAGR in compound percentages) of about 16%. As a result, by 2032 the volume of the industry will reach approximately $10.65 billion.^[3]

2016

Medical robots market reaches $4.9 billion

In 2016, the global market for medical robots amounted to $4.9 billion, according to research company Research and Markets.

According to analysts, in the period from 2016 to 2021, sales of robotic systems used in healthcare, as well as accessories for them, will increase by an average of 21.1% per year and will amount to $12.8 billion by the end of this period of time.

Robot for patient rehabilitation

Experts consider the main growth factors of the market in question to be the advantages of robots in rehabilitation therapy, technological advances, growing investments of medical institutions in robotics, increasing funding for medical robot research and entering the stock exchange of manufacturers of such systems.

Research and Markets divides medical robots into several categories that differ in scope: robots for surgical operations, for rehabilitation activities, for non-invasive radiosurgery, for hospitals and pharmacies. The largest segment is surgical robots, whose sales are growing due to the use of these systems in minimally invasive operations and the high accuracy of such solutions. Robots for laparoscopic operations are in greatest demand in this segment. In addition, this includes systems for orthopedic and neurological operations, as well as devices with automatic control of catheters.

Earlier, Research and Markets predicted the growth of the robot surgeons market by 13.7% per year - from $5.2 billion in 2016 to $14.7 billion by 2024.

In 2016, North America was the largest market for medical robots, but analysts predict the largest growth rate in the Asia-Pacific region, as Japan increasingly approves the use of robotic systems for medical purposes, cancers are widespread in China, and the number of hospital beds is increasing in India.^[4]

According to 2016 Research and Markets, the following companies are the largest manufacturers of medical robots:

• Accuray;
• Arxium;
• EKSO Bionics;
• Hansen Medical;
• Hocoma;
• Intuitive Surgical;
• Kirby Lester;
• Mazor Robotics;
• Omnicell;
• Stryker.

Sales exceeded $5.2 billion in 2016

Research and Markets experts note double-digit growth in the global robotic surgical systems market and expect revenue to nearly triple from 2016 to 2024.

A study published at the end of November 2017 reported that global sales of robotic surgeons brought in $5.2 billion in 2016. In the future, a confident uptrend will continue: the CAGR from 2017 to 2024 will be 13.7%. As a result, at the end of the forecast period, annual sales in the surgical robot market will reach $14.7 billion.

Double-Digit Growth in Global Robotic Surgical Systems Market

Analysts made a reservation that when evaluating, they also included in the result revenue from sales of equipment for web and video conferencing, as well as systems for unified communications and collaboration (Unified Communications and Collaboration, UC&C), since surgical robots are often used in conjunction with such solutions.

Among the main factors contributing to the growth of the market, experts listed the spread of chronic diseases, in particular, diseases of the cardiovascular system, and the demand for minimally invasive operations. At the same time, it is noted that the high cost of the robots themselves and the surgical interventions carried out with their help can impede the development of the industry.

As part of the analysis, specialists distinguish three categories in the market under consideration: tools, robotic systems, auxiliary equipment and services. In 2017, the dominant segment will be the toolkit, which will account for 57.8% of total revenue, and until 2024 this picture will continue.

The classification from an applied point of view included general surgery, operations for urological, gynecological and gastrointestinal diseases, radical prostatectomy, cardiothoracic surgery, colorectal surgery, radiation therapy and others. General surgery was named the dominant direction until 2024.^[5]

See also

• Hirugi robots
• Robots in medicine

Notes